Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre
Author:
Publisher
MDPI AG
Subject
Cancer Research,Oncology
Link
http://www.mdpi.com/2072-6694/3/3/3419/pdf
Reference35 articles.
1. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial;Dearnaley;Lancet,1999
2. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int. J. Radiat. Oncol. Biol. Phys.,2008
3. Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study;Michalski;Int. J. Radiat. Oncol. Biol. Phys.,2010
4. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer;Al-Mamgani;Int. J. Radiat. Oncol. Biol. Phys.,2008
5. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial;Dearnaley;Lancet Oncol.,2007
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prostate cancer intensity-modulated radiotherapy and long term genitourinary toxicity: an evolving therapeutic landscape;Prostate Cancer and Prostatic Diseases;2022-04-29
2. Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: a systematic review and meta-analysis;Prostate Cancer and Prostatic Diseases;2022-03-08
3. Novel purine thioglycoside analogs: synthesis, nanoformulation and biological evaluation in in vitro human liver and breast cancer models;Drug Design, Development and Therapy;2019-07
Novel purine thioglycoside analogs: synthesis, nanoformulation and biological evaluation in in vitro human liver and breast cancer models
4. The collaborative management of late urological complications after radiation therapy;BJU International;2019-05
5. Synergistic locoregional chemoradiotherapy using a composite liposome-in-gel system as an injectable drug depot;International Journal of Nanomedicine;2016-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3